The Europe Aquatic Veterinary Market is projected to grow significantly, reaching an estimated US$ 557.5 million by 2031, up from US$ 439.0 million in 2024. This growth represents a compound annual growth rate (CAGR) of 3.5% from 2025 to 2031.
In April 2021, the European Union introduced a pivotal regulation concerning animal health, aimed at modernizing and simplifying the management of aquatic animal health. This regulation mandates EU member states to formulate multi-year plans that focus on sustainable aquaculture practices. The new guidelines emphasize the reduction of antibiotic usage, the adoption of smarter farming techniques, and preparedness for health risks associated with climate change and emerging diseases. Collectively, these factors create a robust foundation for the continued advancement of the aquatic veterinary market across Europe.
Crabs also contribute significantly to the aquatic food supply, being rich in proteins and essential nutrients while containing low levels of saturated fats. Their consumption is associated with various health benefits, including improved joint and heart health. The increasing global demand for aquatic animals is driving production growth; for instance, crab production in Russia rose from 86.3 thousand metric tons in 2017 to 93.3 thousand metric tons in 2020.
As seafood consumption rises, there is a corresponding need for high-quality produce, which necessitates the provision of proper nutrients and feeds. This demand is met through the administration of vaccines and supplements, further propelling the aquatic veterinary market.
The growth of the aquatic veterinary market in Germany is attributed to ongoing advancements in the aquaculture and fishery sectors. The country hosts numerous aquaculture businesses focused on species such as rainbow trout, common carp, and mussels. In 2021, approximately 18,300 metric tons of fish were produced in Germany by around 2,200 aquaculture enterprises. Notably, mussel production increased by 5.8% to reach approximately 14,300 metric tons in the same year. The rising fish production and heightened awareness of fish health during cultivation are key factors driving market growth in Germany.
In January 2022, a collaborative research initiative between the German Society for Marine Aquaculture and the Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering was launched, aimed at enhancing aquaculture practices and promoting innovative technologies. Such developments are expected to further strengthen the aquatic veterinary market in Germany.
Executive Summary and Market Analysis
The European aquatic veterinary market encompasses several key countries, including the UK, Germany, France, Italy, and Spain, among others. This region is witnessing steady growth driven primarily by the increasing consumer demand for seafood and products derived from aquatic animals. The expansion of Europe’s aquaculture sector is a significant contributor to this trend, as it enhances the supply of fish and other aquatic species. Furthermore, there is a notable rise in investments directed towards research, particularly in the development of vaccines for fish, which plays a crucial role in improving disease management and farming conditions.In April 2021, the European Union introduced a pivotal regulation concerning animal health, aimed at modernizing and simplifying the management of aquatic animal health. This regulation mandates EU member states to formulate multi-year plans that focus on sustainable aquaculture practices. The new guidelines emphasize the reduction of antibiotic usage, the adoption of smarter farming techniques, and preparedness for health risks associated with climate change and emerging diseases. Collectively, these factors create a robust foundation for the continued advancement of the aquatic veterinary market across Europe.
Strategic Insights
Market Segmentation Analysis
The Europe Aquatic Veterinary Market can be segmented based on various criteria:
- By Type: The market is divided into Diagnostic and Treatment segments, with the Treatment segment leading in 2024.
- By Diagnostic Type: This includes Serological, Molecular Diagnosis, DNA Sequencing, and other diagnostic methods, where Molecular Diagnosis was the dominant segment in 2024.
- By Treatment Type: The Treatment segment is further categorized into Vaccines, Medications, and Supplements, with Medications holding the largest share in 2024.
- By Species: The market is segmented into Fish, Crustaceans, Mollusca, and others, with Fish being the predominant category in 2024.
- By Disease Source: This includes Bacterial, Viral, Parasites, and others, where Bacterial diseases were the most significant segment in 2024.
- By Route of Administration: The market is segmented into Water Medication, Medicated Feed, and other routes, with Water Medication being the leading method in 2024.
Market Outlook
Aquatic animals such as fish, crabs, mussels, and lobsters are increasingly consumed by humans, leading to a surge in seafood demand. This demand is propelling the aquaculture industry forward. Fish, in particular, are recognized for their rich nutritional content, including essential vitamins, proteins, fatty acids, and minerals, making them a vital source of omega-3 fatty acids. Research has linked omega-3 fatty acids to numerous health benefits, including a reduced risk of heart disease, prevention of childhood asthma and depression, and enhanced brain health. According to the Organization for Economic Cooperation and Development (OECD), global fish production is expected to reach 200 million metric tons by 2029, with approximately 90% of this production intended for human consumption.Crabs also contribute significantly to the aquatic food supply, being rich in proteins and essential nutrients while containing low levels of saturated fats. Their consumption is associated with various health benefits, including improved joint and heart health. The increasing global demand for aquatic animals is driving production growth; for instance, crab production in Russia rose from 86.3 thousand metric tons in 2017 to 93.3 thousand metric tons in 2020.
As seafood consumption rises, there is a corresponding need for high-quality produce, which necessitates the provision of proper nutrients and feeds. This demand is met through the administration of vaccines and supplements, further propelling the aquatic veterinary market.
Country Insights
The Europe Aquatic Veterinary Market is also analyzed by country, with significant contributions from the United Kingdom, Germany, France, Spain, Italy, and the Rest of Europe. Germany, in particular, held the largest market share in 2024.The growth of the aquatic veterinary market in Germany is attributed to ongoing advancements in the aquaculture and fishery sectors. The country hosts numerous aquaculture businesses focused on species such as rainbow trout, common carp, and mussels. In 2021, approximately 18,300 metric tons of fish were produced in Germany by around 2,200 aquaculture enterprises. Notably, mussel production increased by 5.8% to reach approximately 14,300 metric tons in the same year. The rising fish production and heightened awareness of fish health during cultivation are key factors driving market growth in Germany.
In January 2022, a collaborative research initiative between the German Society for Marine Aquaculture and the Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering was launched, aimed at enhancing aquaculture practices and promoting innovative technologies. Such developments are expected to further strengthen the aquatic veterinary market in Germany.
Company Profiles
Key players in the Europe Aquatic Veterinary Market include Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Virbac SA, Phibro Animal Health Corp., HIPRA SA, Indian Immunologicals Ltd., Esox Biologics Ltd., Ceva Polchem Pvt Ltd., and Aquatic Diagnostics Ltd. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to their customers.Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Aquatic Veterinary Market Landscape
5. Europe Aquatic Veterinary Market - Key Market Dynamics
6. Aquatic Veterinary Market - Europe Market Analysis
7. Europe Aquatic Veterinary Market Revenue Analysis - by Type
8. Europe Aquatic Veterinary Market Revenue Analysis - by Diagnostic Type
9. Europe Aquatic Veterinary Market Revenue Analysis - by Treatment Type
10. Europe Aquatic Veterinary Market Revenue Analysis - by Species
11. Europe Aquatic Veterinary Market Revenue Analysis - by Diseases Source
12. Europe Aquatic Veterinary Market Revenue Analysis - by Route of Administration
13. Europe Aquatic Veterinary Market - Country Analysis
14 Competitive Landscape
15 Industry Landscape
16 COMPANY PROFILES
17. Appendix
LIST OF TABLES
LIST OF FIGURES
Companies
The List of Companies - Europe Aquatic Veterinary MarketThermo Fisher Scientific Inc
Merck KGaA
Zoetis Inc
Virbac SA
Phibro Animal Health Corp
HIPRA SA
Indian Immunologicals Ltd
Esox Biologics Ltd
Ceva Polchem Pvt Ltd
Aquatic Diagnostics Ltd
